Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
- Add to watchlist
- Create an alert
- This stock can be held in a
976.00p
998.00p
1,034.00p
1,058.45
987.00p
973.00p
715.00p
-7.79%
11.00p (1.13%) Previous:
11.00p
87,569
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 2.71% | 1 year 1Y | 24.31% |
---|---|---|---|
1 month 1M | 0.4% | 2 years 2Y | 11.9% |
3 months 3M | 13.06% | 3 years 3Y | 31.08% |
6 months 6M | 25.73% | 5 years 5Y | 42.22% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.30% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £381m |
Gross gearing: | 6% |
Market capitalisation:Market cap.: | £328m |
Shares in issue: | 33.63 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,058.45 |
---|---|
Latest actual NAV: | 1,056.44 |
Latest actual NAV date: | 26 March 2024 |
Premium/Discount: | -7.79% |
12m average Premium/Discount: | -7.73% |
NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Amgen Inc | 9.43% |
Biogen Inc | 6.50% |
Ionis Pharmaceuticals Inc | 6.33% |
Biomarin Pharmaceutical Inc | 6.21% |
Scholar Rock Holding Corp | 5.93% |
Vaxcyte Inc Ordinary Shares | 4.41% |
Quantumpharm Inc (Xtalpi) - Pfd | 4.32% |
Neurocrine Biosciences Inc | 4.08% |
argenx SE ADR | 4.04% |
United Therapeutics Corp | 3.89% |
Sector | Weight |
---|---|
Healthcare | 104.11% |
Country | Weight |
---|---|
United States | 92.40% |
China | 7.77% |
Canada | 1.53% |
Germany | 1.26% |
Netherlands | 1.16% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2024 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.